Epidemiology of Non-Alcoholic Fatty Liver Disease

被引:681
作者
Bellentani, Stefano [1 ]
Scaglioni, Federica [1 ]
Marino, Mariano [1 ]
Bedogni, Giorgio [1 ,2 ]
机构
[1] Azienda USL Modena, Ctr Studi Fegato, Carpi, Italy
[2] Ctr Studi Fegato, Trieste, Italy
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Epidemiology; HEPATIC STEATOSIS; METABOLIC SYNDROME; NATURAL-HISTORY; RISK-FACTORS; TRANSAMINASE ABNORMALITIES; HEPATOCELLULAR-CARCINOMA; INDEPENDENT PREDICTORS; INSULIN-RESISTANCE; CLINICAL-FEATURES; STEATOHEPATITIS;
D O I
10.1159/000282080
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20-30%. About 2-3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80-90% in obese adults, 30-50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3-10%, rising up to 40-70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [21] Psoriasis and non-alcoholic fatty liver disease
    Wenk, K. S.
    Arrington, K. C.
    Ehrlich, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (04) : 383 - 391
  • [22] Non-alcoholic fatty liver disease: A real threat in Pakistan
    Abbas, Zaigham
    Zaheer, Ramsha
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (12-B) : 2437 - 2440
  • [23] Non-alcoholic fatty liver disease in obese children and adolescents
    Denzer, C.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2013, 56 (04) : 517 - 527
  • [24] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [25] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [26] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [27] Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
    Venetsanaki, Vasiliki
    Polyzos, Stergios A.
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 546 - 555
  • [28] Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management
    Huang, Tony
    Behary, Jason
    Zekry, Amany
    INTERNAL MEDICINE JOURNAL, 2020, 50 (09) : 1038 - 1047
  • [29] Current treatment of non-alcoholic fatty liver disease
    Ahmed, Mohamed H.
    Byrne, Christopher D.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03) : 188 - 195
  • [30] Non-alcoholic fatty liver disease: Definition and subtypes
    Han, Seul Ki
    Baik, Soon Koo
    Kim, Moon Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S5 - S16